Journal
JOURNAL OF CLINICAL VIROLOGY
Volume 54, Issue 1, Pages 42-47Publisher
ELSEVIER
DOI: 10.1016/j.jcv.2012.01.022
Keywords
HIV; Rapid tests; Acute HIV infection; Early HIV infection; Fourth-generation
Categories
Funding
- CDC [1UA1 PS000063]
Ask authors/readers for more resources
Background: Although rapid HIV tests increase the number of persons who are aware of their HIV status, they may fail to detect early HIV infection. Objectives: To evaluate the sensitivity for early HIV infection of several rapid tests and third-and fourth-generation assays compared with nucleic acid amplification testing (NAAT). Study design: Sensitivity for early HIV infection was evaluated using 62 NAAT-positive/WB-negative or indeterminate specimens from the CDC Acute HIV Infection study. Specimens underwent third-generation testing with Genetic Systems 1/2 + O (R) and rapid testing with Multispot HIV-1/HIV-2. A subset was also tested with four FDA-approved rapid tests and Determine HIV-1 Antigen/Antibody Rapid Test (R) and Architect HIV Antigen/Antibody Combo (R), both fourth-generation tests. Results: Of 99,111 specimens screened from April 2006 to March 2008, 62 met the definition for early HIV infection (60 NAAT-positive/seronegative and 2 NAAT-positive/Western blot indeterminate). Third-generation testing correctly detected antibody in 34 specimens (55%; 95% confidence interval (CI): 42-67); Multispot detected antibody in 16 (26%; 95% CI: 16-38). Of the 62 specimens, 33 (53%) had sufficient quantity for further testing. Rapid test sensitivities for early HIV infection ranged from 22-33% compared with 55-57% for the third-generation assay and 76-88% for the fourth-generation tests. Conclusions: Many rapid HIV tests failed to detect half of the early HIV infection cases in whom antibody was present. Programs that screen high-incidence populations with rapid tests should consider supplemental testing with NAAT or other antigen-based tests. These data support the need for more sensitive antigen-based point-of-care screening tests for early HIV infection. Published by Elsevier B.V.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available